Clinical Trials for Waldenström's Macroglobulinemia

Find clinical trials for waldenström's macroglobulinemia. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma

NCT ID: NCT05326308

This clinical trial is studying the effectiveness of a medication called zanubrutinib for patients with certain types of blood cancers, including Waldenström's macroglobulinemia, chronic lymphocyti...

Recruiting

Type: observational Locations: Salzburg, Austria, Lübeck, Schleswig Holstein, Germany

R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia

NCT ID: NCT03697356

This clinical trial, called the Ballondor trial, is studying a treatment approach for patients with Waldenström's Macroglobulinemia, a type of blood cancer. The treatment combines rituximab, lenali...

Recruiting

Phase: PHASE2 Type: interventional Locations: Busan, Sue Gu, Korea, Republic Of

A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's Macroglobulinemia

NCT ID: NCT05979948

This clinical trial is studying a new treatment approach for patients with newly diagnosed Waldenström's macroglobulinemia, a type of blood cancer. The researchers are examining how well a drug cal...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions